KCI gains injunction against S&N wound therapy tech
This article was originally published in Clinica
Kinetic Concepts (KCI) has won an injunction against Smith & Nephew regarding its Renasys EZ and Renasys Go negative pressure wound therapy (NWPT) systems in the UK. However, the patents court of the High Court of Justice has granted S&N the right to appeal, meaning the products stay on sale. In June, the court found that S&N’s Renasys systems infringed two KCI patents (www.clinica.co.uk, 25 June 2010). The dispute between the two firms dates back to 2007, when S&N bought BlueSky Medical, a NWPT specialist which was already embroiled in patent litigation with KCI (www.clinica.co.uk, 18 May 2007 and 11 August 2006).
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals